Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV
For instance, BioAge Labs is combining its drug candidate BGE-105 with tirzepatide in a phase 1 study while Regeneron will test its antibody drugs with semaglutide to prevent muscle loss, especially in older patients
Diet-induced rodent models of obesity-related metabolic disorders- a guide to a translational perspective
What FDA Scientists Found and Why They Said No Before the meeting, FDA career scientists completed a systematic review of all seven peptides under the agency's four-part balancing test under 21 CFR 216.23(c): physical and chemical characterization, historical compounding use, evidence of effectiveness, and safety
McLennan SV, Min D, Yue DK
Notably, these behavioral effects are caused by direct central GLP-1R activation